Johna  Norton net worth and biography

Johna Norton Biography and Net Worth

Johna Norton is executive vice president of Global Quality for Eli Lilly and Company.

Johna joined Lilly in 1990 as an analytical chemist. She went on to hold positions with increasing responsibility in quality assurance and quality control, supporting manufacturing and process development at both Lilly facilities and with Lilly’s external manufacturing partners. Throughout her career, she has worked at multiple Lilly manufacturing sites, including sites in Indiana, Ireland and Puerto Rico. Prior to her current role, Johna was vice president, Quality, for Lilly’s Active Pharmaceutical Ingredient manufacturing network, Puerto Rico manufacturing, and Product Research and Development. 

She holds a Bachelor of Science in chemistry from Gannon University and a Master’s in analytical chemistry from Miami University. 

In 2017, FiercePharma named Johna one of the Top Women in Life Sciences.

She serves on the board of directors for United Way of Central Indiana.

What is Johna Norton's net worth?

The estimated net worth of Johna Norton is at least $18.99 million as of June 14th, 2023. Norton owns 31,761 shares of Eli Lilly and Company stock worth more than $18,994,666 as of December 11th. This net worth evaluation does not reflect any other assets that Norton may own. Learn More about Johna Norton's net worth.

How do I contact Johna Norton?

The corporate mailing address for Norton and other Eli Lilly and Company executives is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. Eli Lilly and Company can also be reached via phone at (317) 276-2000 and via email at [email protected]. Learn More on Johna Norton's contact information.

Has Johna Norton been buying or selling shares of Eli Lilly and Company?

Johna Norton has not been actively trading shares of Eli Lilly and Company during the last quarter. Most recently, Johna Norton sold 1,647 shares of the business's stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $444.29, for a transaction totalling $731,745.63. Following the completion of the sale, the executive vice president now directly owns 31,761 shares of the company's stock, valued at $14,111,094.69. Learn More on Johna Norton's trading history.

Who are Eli Lilly and Company's active insiders?

Eli Lilly and Company's insider roster includes Anat Ashkenazi (Sr. VP & CFO ), Melissa Barnes (SVP), Enrique Conterno (SVP), Stephen Fry (SVP), Michael Harrington (VP), Susan Mahony (SVP), Johna Norton (EVP), Myles O'Neill (SVP), Derica Rice (EVP), David Ricks (CEO), Marschall Runge (Director), Aarti Shah (SVP), Christi Shaw (SVP), Jeffrey Simmons (SVP), Daniel Skovronsky (SVP), Joshua Smiley (CFO), Jackson Tai (Director), Jacob Van Naarden (Sr. VP), Alonzo Weems (SVP), Anne White (SVP), Ilya Yuffa (SVP), Donald Zakrowski (CAO), and Alfonso Zulueta (SVP). Learn More on Eli Lilly and Company's active insiders.

Are insiders buying or selling shares of Eli Lilly and Company?

In the last year, insiders at the sold shares 31 times. They sold a total of 2,569,584 shares worth more than $21,741,028,325.10. The most recent insider tranaction occured on November, 6th when CAO Donald A Zakrowski sold 670 shares worth more than $382,637.00. Insiders at Eli Lilly and Company own 0.1% of the company. Learn More about insider trades at Eli Lilly and Company.

Information on this page was last updated on 11/6/2023.

Johna Norton Insider Trading History at Eli Lilly and Company

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2023Sell1,647$444.29$731,745.6331,761View SEC Filing Icon  
See Full Table

Johna Norton Buying and Selling Activity at Eli Lilly and Company

This chart shows Johna Norton's buying and selling at Eli Lilly and Company by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Eli Lilly and Company Company Overview

Eli Lilly and Company logo
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; Foghorn Therapeutics Inc., and PRISM BioLab Co.,Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $584.04
Low: $567.41
High: $601.19

50 Day Range

MA: $585.38
Low: $525.10
High: $619.50

2 Week Range

Now: $584.04
Low: $309.20
High: $629.97


5,610,168 shs

Average Volume

3,080,026 shs

Market Capitalization

$554.44 billion

P/E Ratio


Dividend Yield